ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,055,912 | -64.6% | 36,817 | -70.4% | 0.01% | -61.1% |
| Q1 2023 | $2,981,437 | +220.4% | 124,382 | +126.7% | 0.02% | +260.0% |
| Q4 2022 | $930,510 | +48.6% | 54,865 | +38.0% | 0.01% | +25.0% |
| Q2 2022 | $626,000 | +344.0% | 39,749 | +659.3% | 0.00% | +300.0% |
| Q1 2022 | $141,000 | -81.2% | 5,235 | -66.6% | 0.00% | -88.9% |
| Q3 2021 | $749,000 | +144.8% | 15,684 | +73.5% | 0.01% | +200.0% |
| Q2 2021 | $306,000 | -74.5% | 9,038 | -68.9% | 0.00% | -80.0% |
| Q1 2021 | $1,201,000 | +181.3% | 29,080 | +191.9% | 0.02% | +150.0% |
| Q3 2020 | $427,000 | -71.1% | 9,962 | -68.5% | 0.01% | -76.9% |
| Q2 2020 | $1,477,000 | – | 31,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
| DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
| HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
| Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
| Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
| ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
| Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
| Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
| HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |